Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | CNR2 | P34972 | 1/20 | 0.75 |
| ▸ | RECQL | P46063 | 1/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17035910 | 1.00 | CNR1 (0.75) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL17035902 | 0.94 | CNR1 (0.73) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL10665988 | 0.89 | CNR1 (0.85) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL15126343 | 0.87 | CNR1 (0.81) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL10460131 | 0.86 | CNR1 (0.80) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL2545822 | 0.85 | CNR1 (1.00) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL29385060 | 0.85 | CNR1 (1.00) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| Hydrochloric Acid SCHEMBL9690612 | 0.85 | CNR1 (0.77) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| SCHEMBL9691060 | 0.83 | CNR1 (0.75) | CNR1ALDH1A1TP53CYP1A2CYP3A4 | |
| Pravadoline SCHEMBL30353006 | 0.83 | CNR1 (1.00) | CNR1ALDH1A1TP53CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150239796-A1 | ONE POT SYNTHESIS OF 18F LABELEDTRIFLUOROMETHYLATED COMPOUNDS WITH DIFLUORO(IODO)METHANE | UNIVERSITY OF OSLO (NO) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150239796-A1 | ONE POT SYNTHESIS OF 18F LABELEDTRIFLUOROMETHYLATED COMPOUNDS WITH DIFLUORO(IODO)METHANE | FLI1, AFF1, CYP2F1 | CNR1 926/4885ALDH1A1 293/4885TP53 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.